This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 13 print issues and online access
$259.00 per year
only $19.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Frye MA, Nemeroff CB. Pharmacogenomic testing for antidepressant treatment selection: lessons learned and roadmap forward. Neuropsychopharmacology. 2023. https://doi.org/10.1038/s41386-023-01667-4.
Hicks JK, Bishop JR, Sangkuhl K, Muller DJ, Ji Y, Leckband SG, et al. Clinical pharmacogenetics implementation consortium (CPIC) guidelines for CYP2D6 and CYP2C19 genotypes and dosing of selective serotonin reuptake inhibitors. CPT. 2015;98:127–34.
Bousman CA, Stevenson JM, Ramsey LB, Sangkuhl K, Hicks JK, Strawn JR, et al. Clinical pharmacogenetics implementation consortium (CPIC) guidelines for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A genotypes and serotonin reuptake inhibitor antidepressants. CPT. 2023;114:51–68.
Gold SM, Kohler-Forsberg O, Moss-Morris R, Mehnert A, Miranda JJ, Bullinger M, et al. Comorbid depression in medical diseases. Nat Rev Dis Primers. 2020;6: https://doi.org/10.1038/s41572-020-0200-2.
Loftus J, Levy HP, Stevenson JM. Documentation of results and medication prescribing after combinatorial psychiatric pharmacogenetic testing: a case for discrete results. Genet Med. 2023;26:101056.
Bousman CA, Arandjelovic K, Mancuso SG, Eyre HA, Dunlop BW. Pharmacogenomic tests and depressive symptom remission: a meta-analysis of randomized controlled trials. Pharmacogenomics. 2019;20:37–47.
Author information
Authors and Affiliations
Contributions
Christina Sun drafted the initial correspondence manuscript. Lucas Berenbrok and James Stevenson provided guidance regarding discussion points and reviewed and edited the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Sun, C.N., Berenbrok, L.A. & Stevenson, J.M. Dynamic and accessible pharmacogenomic results: a response to pharmacogenomic testing for antidepressant treatment selection. Neuropsychopharmacol. 49, 769 (2024). https://doi.org/10.1038/s41386-024-01816-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41386-024-01816-3